Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04003649
Title IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

glioblastoma

Therapies

Anti-IL13RA2 CAR T cells

Anti-IL13RA2 CAR T cells + Ipilimumab + Nivolumab

Anti-IL13RA2 CAR T cells + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.